More than 29,000 Kenyans lose their lives to cancer-related illnesses each year, according to data from the Kenya Network of Cancer Organizations (KENCO). Appearing before the National Assembly’s Health Committee, KENCO Executive Director Phoebe Ongadi reported that 44,700 new cancer cases were recorded, noting that the actual numbers could be even higher.
“Locally, we need to strengthen the national registry to collect accurate data. I believe Globocan’s figures may underestimate the true situation on the ground. A comprehensive national cancer registry will help us develop effective strategies and interventions,” Ongadi said.
The advocacy group also highlighted the inadequate funding for cancer patients under the Social Health Authority (SHA), revealing that over 60% of patients exhaust their benefits before the end of the year. Officials told MPs that the transition from the National Health Insurance Fund (NHIF) to SHA has introduced additional barriers for patients seeking chemotherapy, radiotherapy, and follow-up care.
“SHA has increased emotional distress more than the disease itself. Cancer is emotionally taxing, but the SHA system has worsened the situation,” Ongadi stated. “Patients live in constant fear about whether their treatment will be approved, when their financial year starts, or if they will be required to pay out of pocket. These uncertainties are creating more turmoil than the disease itself.”
MPs were informed that thousands of patients are forced to abandon treatment due to the high costs once their SHA benefits are depleted. According to KENCO, 60% of cancer patients exhaust their SHA cover before the year ends, 35% within the first three months, and 13% are compelled to stop treatment altogether.
The financial burden of cancer treatment in Kenya is alarming. KENCO estimates that families spend an average of Ksh.3.8 million annually to support a loved one with cancer. The costs of chemotherapy, radiotherapy, surgery, and follow-up medication have turned cancer into both a medical and financial crisis.
According to KENCO’s submissions to Parliament, a woman diagnosed with triple-positive breast cancer and treated at a public health facility can spend in excess of Ksh.3.8 million in total, underscoring the urgent need for enhanced support systems and funding for cancer patients.
